Engineering inducible transcription factors to generate human functional blood cells for cell therapy
Projektnummer
0065840
Zusammenfassung
Among stem cells, which originate and maintain human life, hematopoietic stem cells give rise to all functional blood cells, including immune cells, and therefore are used for transplantation in the treatment of cancers and immune system disorders. As long-term ex vivo expansion of hematopoietic stem and progenitor cells (HSPCs) seems to be unattainable, there is an urgent need to identify methods to accomplish efficient progenitor cell expansion. Here the research group outlines the concept of using leukemia-associated engineered inducible transcription factors (iTFs) conferring susta...
Projektinformationen
Status:
Beendet
Startdatum:
01.11.2020
Enddatum:
30.04.2022
Fördersumme:
96.600 €
Profilbereich:
Beendete Förderinitiativen
Förderinitiative:
Experiment! Auf der Suche nach gewagten Forschungsideen
Ausschreibung:
Experiment! Explorative Phase